PATHOGENIC CONTROL OF APOPTOSIS
Overview of innovation
The present invention relates to methods and compositions for modulating the control of apoptosis, specifically for modulating the interaction between hnRNP-K and lincRNA-p21 to induce or prevent apoptosis in the cell.
Type of Intellectual Property protection
Patent
Innovation Opportunity Type
Licensing
Industry
Manufacturing
Other manufacturing
Technology Readiness Level
TRL 4 – Experimental prototype developed